HHS budget proposal eliminates CDC's chronic disease, global health centers in favor of new "MAHA" agency
The Department of Health and Human Services' budget request for the 2026 fiscal year consolidates the department's 28 divisions to 15 to make way for a new "institution of public health."
The new agency, the Administration for a Healthy America, has a $20.6 billion budget designed to support Health Secretary Robert F. Kennedy Jr.'s "Make America Healthy Again" agenda. That includes taking over — and significantly reducing — funds for the Centers for Disease Control and Prevention's chronic disease and global health centers along with some of the institutes that are currently part of the National Institutes of Health.
The Administration for a Healthy America, or AHA, says it will take a "root cause" approach to chronic disease prevention, according to the agency's budget request, released last Friday. But the budget proposes cutting funding for all programs in the CDC's chronic disease center and would make significant cuts to existing primary care, mental health and environmental health programs.
The cuts slash the CDC's budget from nearly $9.2 billion in FY 2024 to $4.2 billion. At least 20%, or $1 billion, of the funding cut is moving to AHA.
The cuts will have a trickle-down effect on states and cities. The vast majority of CDC funding is discretionary and funneled to state and local health departments. Last year, these departments received $4.5 billion of CDC funding to "promote and protect health in their communities."
And even where funds are maintained, the restructuring could come at a cost, according to Richard Frank, director of the Center on Health Policy at the Brookings Institution.
"The CDC has over the years developed a lot of human capital," Frank said. The agency's infectious disease response, involving surveillance and expert teams sent to the source of an outbreak, is "not something you learn overnight that you can just move around easily without disrupting how effective it is."
The budget request also cuts the NIH by about 40% and dissolves agencies including the Substance Abuse and Mental Health Services Administration and the Health Resources Service Administration.
"The Budget reflects needed reforms to put health care spending on a sustainable fiscal path and proposes policies to Make America Healthy Again," HHS press secretary Emily Hilliard wrote in a statement to CBS News. "The United States remains the sickest developed nation despite spending $4.5 trillion annually on health care, resulting in an exploding debt that poses a critical threat to our country along with worsening health outcomes."
Kennedy has repeatedly decried the "childhood chronic disease crisis" in America. That was a central focus of his "Make America Healthy Again" commission report. The report has been criticized for citing studies that do not exist, including false information and omitting established drivers of chronic disease in children that health authorities are already working to address.
Chronic disease prevention
The latest budget request would eliminate the CDC's Center for Chronic Disease Prevention and Health Promotion, for which $1.4 billion was appropriated in FY 2024. Instead, AHA would fund primary care, environmental health, mental health and nutrition programs. This, according to the department, would prevent chronic disease from the source, rather than fund individual programs on cancer, diabetes, heart disease and other diseases as the CDC's chronic disease center did.
Nearly 70 organizations, including the American Heart Association and the American Association of Colleges of Nursing, signed a letter to leaders of the House and Senate appropriations committees in mid-May, after an earlier version of the budget was leaked. They expressed their opposition to the budget's elimination of the CDC's chronic disease center.
The programs in the center "work with states and territories to prevent disease, detect it early, and manage it effectively," said the letter. Eliminating them "would destabilize public health systems at every level and jeopardize decades of progress."
Global health
The FY 2026 budget request eliminates the CDC's Global Health Center, and instead allocates $239 million toward global health protection, under the CDC's broader "CDC-Wide Activities" budget line. The Global Health Center spent $711 million in FY 2024.
Defunding the center comes alongside the Trump administration's dismantling of the U.S. Agency for International Development and withdrawal from the World Health Organization. These actions will have consequences for Americans in addition to those abroad, said Janeen Madan Keller, deputy director of the Global Health Policy Program at the Center for Global Development, a think tank based in Washington, D.C.
"From our own experience with epidemics and pandemics, we know that infectious diseases do not respect borders," Keller said. "It's really important that we have the ability to stop these outbreaks in their tracks before they reach our border."
Other programs
AHA consolidates federal HIV/AIDS prevention and research. It cuts $794 million of the CDC's funding for domestic HIV/AIDS prevention and takes over HIV/AIDS programs from other agencies. In total, AHA allocates a combined $2.7 billion to the virus and resulting disease — almost $1 billion less than those programs were appropriated in FY 2024.
Other centers moved from the CDC include its centers for Birth Defects, Developmental Disabilities, Disability and Health, Injury Prevention and Control, and Occupational Safety and Health. Some of the funding from these centers has been moved to broader programs within AHA, according to the budget proposal.
Before the budget is passed, it will be reviewed by congressional subcommittees before the House and Senate prepare their own budget resolutions later this year.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
New York Times
14 minutes ago
- New York Times
People With Severe Diabetes Are Cured in Small Trial of New Drug
A single infusion of a stem cell-based treatment may have cured 10 out of 12 people with the most severe form of type 1 diabetes. One year later, these 10 patients no longer need insulin. The other two patients need much lower doses. The experimental treatment, called zimislecel and made by Vertex Pharmaceuticals of Boston, involves stem cells that scientists prodded to turn into pancreatic islet cells, which regulate blood glucose levels. The new islet cells were infused and reached the pancreas, where they took up residence. The study was presented Friday evening at the annual meeting of the American Diabetes Association and published online by The New England Journal of Medicine. 'It's trailblazing work,' said Dr. Mark Anderson, professor and director of the diabetes center at the University of California in San Francisco. 'Being free of insulin is life changing,' added Dr. Anderson, who was not involved in the study. Vertex, like other drug companies, declined to announce the treatment's cost before the Food and Drug Administration approves it. The treatment, said Vertex spokeswoman Dee Smith, could potentially help all patients with type 1 diabetes, although they would need to weigh the risks against the benefits of possibly not needing insulin. Want all of The Times? Subscribe.
Associated Press
15 minutes ago
- Associated Press
NthJEN Announces the Launch of Revolutionary Smart Bed Technology to Prevent Bedsores and Patient Falls
06/20/2025, Overland Park, Kansas // PRODIGY: Feature Story // After nearly a decade of development, testing, and clinical feedback, NthJEN LLC announces the launch of its breakthrough multi-sensor smart bed technology into the healthcare market. Designed to monitor immobility, alert clinicians of risk, and help prevent injuries, the solution stands at the intersection of compassion, precision, and innovation. Founder and CEO Naveen Gogumalla calls it 'a just-in-time, technology-based solution for one of the most overlooked problems in healthcare.' NthJEN's smart bed system, powered by a thin, pressure-sensitive membrane layered over any standard bed, uses over a thousand sensors to continuously map the patient's pressure distribution and activity. Unlike traditional methods that rely on visual checks or outdated alarms, the system detects early signs of immobility or unsafe patterns that can lead to pressure ulcers or dangerous falls. It can even detect if a patient has gotten out of bed and failed to return within a safe timeframe, alerting staff in real-time. 'It's not just about alarms, it's about precision alerts that matter,' says Gogumalla. 'We have designed this system to reduce alarm fatigue by only alerting caregivers when necessary. If the patient is out of bed too long or has not moved in a high-risk position, that's when the system speaks up.' The journey to market began in 2017, when Gogumalla, whose background spans IT and healthcare, was approached by a wound care nurse desperate for a real solution. 'She said everyone was trying to help us with these wounds, but no one was solving the core issue,' he recalls. Motivated by that challenge, and deeply affected by the untimely passing of his sister due to a cardiac event, Gogumalla redirected his efforts to build something that could truly make a difference. 'I kept thinking, how can we use technology to keep people safe? That's what drove this,' he says. What emerged was a durable medical device that could be prescribed by physicians, used in homes or care facilities, and integrated into existing hospital infrastructure. The product is durable, waterproof, and reusable. It straps securely to the bed, reads pressure changes through advanced sensors, and communicates data to clinicians and caregivers via a web-based dashboard. In the future, NthJEN aims to consolidate even more clinical monitoring into the device, vitals, telemetry, and ambient sensors, all in one discreet system. 'One of the core advantages is remote access,' says Gogumalla. 'Family members can receive email alerts or log in to view the bed status. In an age where loved ones are spread across cities or countries, this level of connection provides peace of mind.' Over five years of testing have proven the product's resilience in both clinical and home environments. The system's data logging capabilities can even aid litigation defense by documenting caregiver responses to alarms. According to Gogumalla, the solution helps not just the patient, but the entire ecosystem of care. 'This makes the caregiver more efficient. You don't need to walk in and check unless the alert tells you something's wrong. That changes everything,' he states. The market demand is clear. In the U.S. alone, pressure ulcers and falls account for over $50 billion in treatment and liability costs annually. With the smart bed's ability to detect inactivity or absence before harm occurs, NthJEN offers prevention, not just response. And while some competitors use in-room cameras or rudimentary pressure sensors, NthJEN stands apart. 'We are not trying to map wounds. We are trying to prevent them,' Gogumalla clarifies. 'And we don't believe in turning bedrooms into surveillance zones. This system respects patient dignity while still improving care.' Gogumalla and his team are already working with experienced physical therapists, home care networks, and hospitals to bring the solution into more hands. 'Our vision goes beyond the bed,' he adds. 'We are working toward a future where the hospital room is less cluttered, more integrated, and remotely accessible. Imagine a doctor standing on a beach and checking your vitals remotely from the same system.' For Gogumalla, though, the focus remains grounded. 'This is not about me,' he says. 'It's about solving a real problem and getting it into the hands of people who need it: nurses, patients, caregivers, families. That's who we built it for.' Media Contact Name: Naveen Gogumalla Email: [email protected] The information provided in this article is for educational and informational purposes only and is not intended as medical advice. It is not a substitute for professional medical diagnosis, treatment, or care. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read in this article. Source published by Submit Press Release >> NthJEN Announces the Launch of Revolutionary Smart Bed Technology to Prevent Bedsores and Patient Falls
Associated Press
15 minutes ago
- Associated Press
Ibogaine by David Dardashti Forges Strategic Partnership with Psychedelic University to Cultivate Next-Generation Leaders in Psychedelic Healthcare
MIAMI, FL - June 20, 2025 - Ibogaine by David Dardashti, a pioneering leader in ibogaine-assisted therapy and led by visionary David Dardashti, today announced a groundbreaking collaboration with a Psychedelic University. This strategic partnership aims to establish robust internship opportunities for students passionate about contributing to the rapidly evolving psychedelic field, with initial networking prospects to be explored at the highly anticipated Psychedelic Conference 2025. The initiative is further amplified by the recent opening of Ibogaine by David Dardashti's second state-of-the-art treatment facility, significantly expanding the scope for student involvement. This innovative alliance is designed to bridge the gap between academic learning and practical application, providing students with invaluable hands-on experience in a clinical setting dedicated to transformative healing. The expansion into a second facility dramatically increases Ibogaine by David Dardashti's capacity, creating a diverse array of potential roles for aspiring professionals. 'We are incredibly excited to partner with Psychedelic University to nurture the next generation of leaders in psychedelic medicine,' said David Dardashti, founder of Ibogaine by David Dardashti. 'The opening of our second clinic is not just about expanding our treatment capabilities; it's about building a robust ecosystem where ambitious students can gain real-world experience and help accelerate the growth and acceptance of ibogaine therapy. We believe this collaboration will foster innovation and ethical practices crucial for the future of this field.' The internship program will offer multifaceted opportunities for students from various disciplines. Beyond direct clinical exposure, students can expect to engage in critical areas such as: Meetings will be held in the months following a patient's treatment, creating a unique longitudinal learning environment where interns can observe the full spectrum of patient journeys and recovery. This comprehensive approach ensures that students gain a holistic understanding of patient care, from initial intake to long-term integration support. Representatives from both Ibogaine by David Dardashti and Psychedelic University will be actively engaging with students at the Psychedelic Conference 2025, providing a premier platform for aspiring interns to learn more about these opportunities and network with pioneers in the field. This direct interaction will allow students to present their aspirations and demonstrate their commitment to this burgeoning area of healthcare. The ultimate goal of Ibogaine by David Dardashti is to expand its new clinic with the support of ambitious, dedicated students who are eager to contribute to accelerating the growth and responsible application of ibogaine treatment. This partnership underscores a shared commitment to innovation, education, and the widespread, ethical integration of psychedelic therapies into mainstream healthcare. Media Contact Company Name: Ibogaine By David Dardashti Contact Person: Cole Barressi Email: Send Email Country: United States Website: Press Release Distributed by To view the original version on ABNewswire visit: Ibogaine by David Dardashti Forges Strategic Partnership with Psychedelic University to Cultivate Next-Generation Leaders in Psychedelic Healthcare
